The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has been known to scientists and the public. There has been some progress ...
19don MSN
RNA technology 'hacks' into phage replication, offering new insights into molecular interactions
Bacteriophages, or phages for short, are viruses that infect bacteria. Using phages therapeutically could be very useful in ...
DURING THE covid-19 pandemic new vaccines were rolled out with unprecedented speed. The fastest to arrive were jabs built from molecules of messenger RNA (mRNA) designed to teach the body how to fight ...
Biotech company Factor Bioscience sued rival Cellectis and pharmaceutical giant AstraZeneca in Delaware federal court on ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. AbbVie is entering a collaboration and license option deal ...
That’s now happening. Researchers have uncovered genes that play a role in a number of chronic conditions. And they have invented new types of therapies to target their genetic roots. One of the most ...
GC Biopharma (006280.KS), a leading South Korean pharmaceutical company, announced today that it has submitted an ...
Amid mounting concerns about the spread of mpox, an experimental vaccine from Moderna Inc. may be poised to offer additional protection beyond currently available vaccines, research published ...
- Collaboration to leverage AbbVie's expertise in biotherapeutic drug development and commercialization together with ADARx's proprietary RNA technology to advance next-generation siRNA therapies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results